Privacy    
 
  Citi Research Disclosures


ABCDEFGHIJKLMNOPQRSTUVWXYZ#




Disclosures Home
Conflicts Management Policy
SEBI Investor Charter & Complaint Information
SEBI Prescribed Client Terms & Conditions
Staff Conflicts
Terms of Use

 
Valuation & Risks ( AADA.NS ) Disclosure / Price Chart(s) / Valuation & Risk
Fundamental Equity Research
Using a two-stage Gordon Growth model, we arrive at a target price of Rs650 per share for Aadhar assuming CoEs of 12.2%, medium-term RoEs of 16%, and high growth phase of 10 years with expected growth of 20%. We assign price-to-book of 3.3x 9MFY27E BV.

Key downside risks for Aadhar are - Build-up of stress in LAP over and above expectations; roll-back from elevated GS3 getting disrupted due to activity slowdown also leading to growth slowdown.

 

 

citiPrivacy
www.citigroup.com Terms, conditions, caveats, and small print
Copyright © 2025 Citi